Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease
Authors
Keywords
Alzheimer’s disease, APPswe/PS1ΔE9, mGluR5, Beta amyloid, FMRP, Learning and memory
Journal
Molecular Brain
Volume 7, Issue 1, Pages 40
Publisher
Springer Nature
Online
2014-05-29
DOI
10.1186/1756-6606-7-40
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Tau pathology involves protein phosphatase 2A in Parkinsonism-dementia of Guam
- (2014) M. Arif et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease
- (2013) Valeriy G. Ostapchenko et al. JOURNAL OF NEUROCHEMISTRY
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- The regulation of AβPP expression by RNA-binding proteins
- (2012) Cara J. Westmark et al. AGEING RESEARCH REVIEWS
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- The role of G protein-coupled receptors in the pathology of Alzheimer's disease
- (2011) Amantha Thathiah et al. NATURE REVIEWS NEUROSCIENCE
- The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
- (2011) Sergio T. Ferreira et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links
- (2011) D. K. Sokol et al. NEUROLOGY
- Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
- (2011) Cara J. Westmark et al. PLoS One
- Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain
- (2010) Flavio H. Beraldo et al. FASEB JOURNAL
- Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease
- (2010) F. M. Ribeiro et al. JOURNAL OF NEUROSCIENCE
- Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
- (2010) E. K. Osterweil et al. JOURNAL OF NEUROSCIENCE
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
- (2010) Marianne Renner et al. NEURON
- Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
- (2009) Timothy P. O’Leary et al. BEHAVIOURAL BRAIN RESEARCH
- Phosphorylation-independent Regulation of Metabotropic Glutamate Receptor 5 Desensitization and Internalization by G Protein-coupled Receptor Kinase 2 in Neurons
- (2009) Fabiola M. Ribeiro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NMDA receptors in clinical neurology: excitatory times ahead
- (2008) Lorraine V Kalia et al. LANCET NEUROLOGY
- Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis
- (2008) Arturas Volianskis et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started